Furegrelate
Furegrelate
Furegrelate (pronounced: fyoo-REG-re-late) is a pharmaceutical drug used in the treatment of thrombosis and related conditions.
Etymology
The term "Furegrelate" is derived from its chemical structure, which includes a furan ring and a grelate group. The prefix "Fur-" comes from the Latin "furfur", meaning "bran", and refers to the furan ring in the molecule. The suffix "-grelate" is a common suffix for drugs that inhibit platelet aggregation, such as clopidogrel and pragrelate.
Usage
Furegrelate is primarily used as an antiplatelet agent to prevent the formation of blood clots (thrombi) in the blood vessels. It works by inhibiting the action of the enzyme thromboxane A2 synthase, thereby reducing the production of thromboxane A2, a substance that promotes platelet aggregation and blood vessel constriction.
Related Terms
- Thrombosis: The formation of a blood clot inside a blood vessel, obstructing the flow of blood.
- Antiplatelet drug: A type of medication that decreases platelet aggregation and inhibits thrombus formation.
- Thromboxane A2: A type of eicosanoid that promotes platelet aggregation and blood vessel constriction.
- Thromboxane A2 synthase: An enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.
See Also
External links
- Medical encyclopedia article on Furegrelate
- Wikipedia's article - Furegrelate
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski